NCT00881868

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

A Multi-Center, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Clobetasol Propionate Spray Versus Vehicle for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 81 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.

Conditions

• Scalp Psoriasis

Interventions

Type	Name	Description
DRUG	clobetasol propionate spray 0.05%	Apply enough product to cover affected areas topically twice daily at least 8 hours apart
DRUG	Vehicle spray	Apply enough product to cover affected areas topically twice daily at least 8 hours apart

Timeline

• Start date: 2009-04-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2009-04-15
• Last updated: 2022-08-25
• Results posted: 2010-12-23

Locations

4 sites across 1 country: United States